SCHEMBL3219332

SCHEMBL3219332

COc1cc(C=CC(=O)CC(=O)C=Cc2ccc(O)cc2)cc(OC)c1O

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 10/20 0.82
AKR1B1 P15121 3/20 0.77
MAOB P27338 3/20 0.77
ABCB1 P08183 2/20 0.77
MAOA P21397 2/20 0.77
NFE2L2 Q16236 3/20 0.68
PTGES O14684 2/20 0.68
ALOX5 P09917 2/20 0.68
PTGS1 P23219 2/20 0.68
STAT3 P40763 2/20 0.68
APP P05067 4/20 0.67
MAPT P10636 4/20 0.67
CYP2D6 P10635 3/20 0.67
CYP2C9 P11712 3/20 0.67
TSHR P16473 2/20 0.67
HSD17B10 Q99714 2/20 0.67
PTGS2 P35354 2/20 0.67
GLO1 Q04760 2/20 0.67
CAMK2A Q9UQM7 2/20 0.67
CYP1A2 P05177 2/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3219319 1.00 BACE1 (0.82) BACE1AKR1B1MAOBABCB1MAOA
SCHEMBL13237036 0.91 ALOX5 (0.79) BACE1AKR1B1MAOBABCB1MAOA
SCHEMBL14875131 0.91 ALOX5 (0.79) BACE1AKR1B1MAOBABCB1MAOA
SCHEMBL3218740 0.90 BACE1 (1.00) BACE1AKR1B1MAOBABCB1MAOA
SCHEMBL3218759 0.90 BACE1 (1.00) BACE1AKR1B1MAOBABCB1MAOA
SCHEMBL3206013 0.88 NFE2L2 (0.85) BACE1AKR1B1MAOBABCB1MAOA
SCHEMBL3206032 0.88 NFE2L2 (0.85) BACE1AKR1B1MAOBABCB1MAOA
SCHEMBL31206242 0.87 APP (0.89) BACE1AKR1B1MAOBABCB1MAOA
SCHEMBL14586438 0.87 APP (0.89) BACE1AKR1B1MAOBABCB1MAOA
SCHEMBL21327853 0.87 ABCB1 (1.00) BACE1AKR1B1MAOBABCB1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8962674-B2 Curcumin derivative TOKYO INSTITUTE OF TECHNOLOGY (JP) 2015-02-24 US disclosed
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE TOKYO INSTITUTE OF TECHNOLOGY (JP) 2010-02-25 US disclosed
EP-2123637-A1 NOVEL CURCUMIN DERIVATIVE Tokyo Institute of Technology (JP) 2009-11-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE BACE1, APP, BACE2 BACE1 1/4885AKR1B1 1096/4885MAOB 969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.